Maintenance Cabozantinib in Metastatic Urothelial Carcinoma

from Oncology Learning Network · host HMP Global

Robert Jones, MD, University of Glasgow, UK, shares results and insights from the phase 2 ATLANTIS trial, evaluating maintenance cabozantinib following chemotherapy for patients with metastatic urothelial carcinoma who were negative for DNA repair biomarkers

Episode metadata supplied by the publisher feed · Published Jun 22, 2022

Embed this episode

Attribution link and audio player

Ready to play

Maintenance Cabozantinib in Metastatic Urothelial Carcinoma

0:00 4:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Learning Network?

This episode is 4 minutes long.

When was this Oncology Learning Network episode published?

This episode was published on June 22, 2022.

Can I download this Oncology Learning Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!